Integrated Core Strategies (US) LLC 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 4:32 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 2,990,279 7.100% |
1,592,897 (+113.99%) |
Filing |
| 2023-06-08 4:30 pm Purchase |
2023-06-06 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 1,397,382 5.700% |
1,397,382 (New Position) |
Filing |